euro adhoc: Marseille-Kliniken AG / Board of Directors (Appointments and Changes) / - Mr. Peter Paul Gardosch is a new member of the Marseille-Kliniken AG Board - Expansion in the field of acute clin

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

05.06.2008

Berlin, June 5, 2008. The Supervisory Board of the Marseille-Kliniken
AG (Prime Standard, ISIN DE 0007783003, MKA) has named Mr. Peter Paul
Gardosch (49) as a new member of the Board of the Marseille-Kliniken
AG effective August 1, 2008.

Mr. Peter Paul Gardosch will take over responsibility for the
operative units of Acute Clinics and Rehabilitation. He will be
helping increase the number of locations of acute clinics and, at the
same time, taking the opportunity to take over shareholdings in acute
clinics in the mid-range segment when larger competitors cannot hold
shares in such clinics due to anti-trust regulations. The company is
also planning to replace the coming revenue cuts from other fields by
selling its unit for Rehabilitation. The Marseille-Kliniken AG is
working to take over at least one acute clinic for basic and
regulated care within one year.

The new member of the Board, Mr. Peter Paul Gardosch, brings along
enormous expertise for his work in the field of acute clinics. He
finished his studies in Human Medicine at the University of Hamburg
and worked for many years as an emergency physician. After his
studies, Mr. Gardosch started as an EMS physician for the German Army
before joining the international Solvay Group in 1992 as Director of
Clinical Research. In 1995, Mr. Gardosch was entrusted with advising
hospitals for the celebrated firm of consultants Roland Berger and
helped more than 50 medium-sized companies in industry and the
trades. In 1999, he began building his own consulting company for
companies active in the field of acute medicine. From 2003 to 2006,
Mr. Gardosch worked as CEO of the Humaine Group responsible 10 acute
clinics with 2,100 beds and sales of 230 mill. Euros. The company was
later sold to the Helios Corporation. After this, from 2006 to 2008,
Mr. Gardosch continued to work at his own consulting company.

The Marseille-Kliniken AG has already been working successfully for
the past two years in the field of acute clinics at the St. Nikolas
Hospital in Büren in connection with a care facility there. The St.
Nikolaus Hospital is inteded to be a hospital specialising in
geriatrics to meet the growing need for age-specific treatment while
taking account of normal co-morbidity. Presently, a Medical Care
Centre (MCC) is being set up to assure integrated care for patients.

End of ad hoc release

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Marseille-Kliniken AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Marseille-Kliniken AG

Axel Hölzer

CEO

Alte Jakobstraße 79/80

10709 Berlin

GERMANY

Tel.: +4930 / 246 32-400

Fax: +4930 / 246 32-401

www.marseille-kliniken.com

or

Hillermann Consulting

Christian Hillermann

Investor Relations for Marseille-Kliniken AG

Poststraße 14/16

20354 Hamburg

GERMANY

Tel.: +4940 / 320 279 10

Fax: +4940 / 320 279 114

www.hillermann-consulting.de

Branche: Pharmaceuticals
ISIN: DE0007783003
WKN: 778300
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hamburg / regulated dealing